NCT05468489 2025-10-21To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCShanghai Henlius BiotechPhase 3 Active not recruiting200 enrolled